SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Emily Dickinson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEmily Dickinson
Date of birth1830-12-10
IdentifiersMRN HR-NI023-SYN-TD; SSN (made up) 000-23-6081
Document date1885-06-01
AuthorLucinda Hartwell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month kidney and blood pressure review at home. [S]

History of Present Illness

Ms. Dickinson is seen at home six weeks after her gastroenteritis. The repeat metabolic panel planned for two to three days after the sick visit was not drawn: she felt better by the second day and asked the phlebotomy service not to come. After a nurse call she restarted losartan, dapagliflozin, and amlodipine on the third day, once she had eaten and drunk normally for 24 hours. She has felt well since. Her home blood pressure averages 122/76. She has had no headaches for six weeks, sleeps about seven hours, and is writing full mornings. She has had no ankle swelling on amlodipine and no lightheadedness. She keeps the sick-day card in her medicine cabinet. [S]

ElementDetail
Interval illnessViral gastroenteritis six weeks ago with a prerenal creatinine rise; recovered
Missed checkMetabolic panel planned for two to three days after the sick visit was not drawn
MedicinesRestarted on the third day after a nurse call; taken daily since
Home blood pressureAverage 122/76 mmHg
SymptomsNo headaches for six weeks; sleeping about seven hours; no ankle swelling

Review of Systems

SystemResultFinding
GastrointestinalNegativeNo nausea, vomiting, or diarrhea since recovery
CardiovascularNegativeNo ankle swelling, palpitations, or lightheadedness
NeurologicalNegativeNo headaches for six weeks
PsychiatricNegativeMood good; PHQ-9 3

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter)Two tablets as needed, up to twice a dayOral route1884-10-01 to 1885-01-12stoppedS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12 to 1885-02-02completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-02-02activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12activeS
Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a dayTwo tablets every 6 hours as needed; maximum 6 tablets a dayOral route1885-01-12activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-02-02activeS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-03-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1885-06-01Body height163cmS
1885-06-01Body weight53.2kgS
1885-06-01Body mass index (BMI) [Ratio]20kg/m2S
1885-06-01Systolic blood pressure124mm[Hg]S
1885-06-01Diastolic blood pressure76mm[Hg]S
1885-06-01Heart rate70/minS
1885-06-01Respiratory rate14/minS
1885-06-01Body temperature36.6CelS
1885-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1885-06-01Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1885-06-01Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1885-06-01Carbon dioxide, total [Moles/volume] in Serum or Plasma24mmol/L22-29 mmol/LNormalS
1885-06-01Urea nitrogen [Mass/volume] in Serum or Plasma22mg/dL6-21 mg/dLHighS
1885-06-01Creatinine [Mass/volume] in Serum or Plasma1.3mg/dL0.59-1.04 mg/dLHighS
1885-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1880)/1.73 sq M49mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1885-06-01Glucose [Mass/volume] in Serum or Plasma91mg/dL70-99 mg/dLNormalS
1885-06-01Albumin/Creatinine [Mass Ratio] in Urine118mg/g<=30 mg/gHighS
1885-06-01Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Physical Exam

Vital signs recorded on 1885-06-01; see the Vital Signs section. [S]

SystemFinding
GeneralWell, at her writing table
CardiovascularRegular rhythm; no murmur; no ankle edema
MouthMoist mucous membranes
Mental statusAlert and engaged; mood "well"; reactive affect

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificateactiveconfirmed N18.31S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists.
Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertensionactiveconfirmed I12.9S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists.
Vitamin D deficiency with a mildly raised PTH in chronic kidney diseaseactiveconfirmed E55.9S — Synthetic laboratory finding at the intake visit.
Viral gastroenteritis with volume depletion and a prerenal rise in creatinine while taking losartan and dapagliflozin; resolvedresolvedconfirmed A08.4S — Synthetic illness at an unscheduled home visit, chosen to teach sick-day rules in chronic kidney disease; it does not echo any documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryMetabolic panel two to three days after the prerenal creatinine riseWithin days after acute kidney injury or a sick-day pauseDeferredNot drawn, a deviation from the plan: she felt better on the second day and declined the home draw, and the medicines were restarted after a nurse call without a recheck. No harm, judging by today's creatinine of 1.30 mg/dL and potassium of 4.7 mmol/L. Corrective action: after any kidney injury, the recheck is booked as a firm home draw before the clinician leaves, and the nurse confirms it was done before advising a restart
LaboratoryMetabolic panel with each eGFR drawWith each eGFR draw; more often on an ARB or SGLT2 inhibitorCompleted todayPotassium 4.7 mmol/L, bicarbonate 24 mmol/L, creatinine 1.30 mg/dL, eGFR 49
LaboratoryUrine albumin-creatinine ratioTwice a year at G3a A2 (KDIGO heat map); about 3 months after starting treatment to judge responseCompleted today118 mg/g, down about half from 240
ExaminationStandardized office and home blood pressureEvery visitCompleted today124/76 mmHg at the home visit; home average 122/76
ExaminationWeight and cardiac auscultationEvery visitCompleted today53.2 kg; regular rhythm; no edema on amlodipine
SurveyPHQ-9Yearly with hypertension; repeat if symptoms changeCompleted today3, down from 6 as headaches and sleep improved
Medication safetyMedication review: NSAID avoidance, sick-day rules, and SGLT2 inhibitor safetyEvery visitCompleted todayNo NSAIDs; no genital or urinary symptoms; sick-day card in place
Medication safetyVaccination reviewYearly in chronic kidney diseaseCompleted todayHepB-CpG dose 1 given today; PCV20 in January; influenza due in the autumn
LaboratoryCalcium, phosphate, PTH, and 25-hydroxyvitamin DEvery 6 to 12 months at G3a; vitamin D repeated after repletionDueAt the six-month review, about eight months after baseline
Self-managementSodium, activity, and home readingsEvery visitCompleted todayLow-salt cooking; garden work most afternoons; weekly home readings

Goal progress:

Immunizations given today: Hepatitis B vaccine, CpG-adjuvanted (HepB-CpG), dose 1 of 2 [S]

Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021); 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026)

Follow-up: Video visit in about four months with home vital signs and home blood and urine tests. Next scheduled visit 1885-09-28: video visit for the six-month kidney review, with home vital signs and home blood tests. [S]